Table 6.
Comparison of Semantics-based techniques for recovering and decomposing Swanson’s Associations
| Assoc. | 1.1 | Prostaglandin (PGE1) → INHIBITS → platelet aggregation → CAUSES → Raynaud Syndrome | ||
| Subgraph | 73 | Eicosapentaenoic Acid DISRUPTS Platelet aggregation | Alprostadil DISRUPTS Platelet aggregation | Alprostadil INTERACTS_WITH Raynaud Disease |
| Assoc. | 1.2 | Prostacyclin (PGI2) → INHIBITS → platelet aggregation → CAUSES → Raynaud Syndrome | ||
| Subgraph | 77 | Eicosapentaenoic Acid DISRUPTS Platelet aggregation | Epoprostenol DISRUPTS Platelet aggregation | Epoprostenol TREATS Raynaud Disease Epoprostenol TREATS Raynaud Phenomenon |
| 78 | ||||
| 80 | Epoprostenol INHIBITS_MAN Platelet aggregation | |||
| 81 | ||||
| 83 | Epoprostenol PREVENTS_MAN Platelet aggregation | |||
| 84 | ||||
| 135 | Eicosapentaenoic Acid STIMULATES Epoprostenol | |||
| 150 | ||||
| Assoc. | 1.3 | Nifedipine → ISA → CCB → INHIBITS → platelet activation → ASSOCIATED WITH → Raynaud Syndrome | ||
| Subgraph | 91 | Eicosapentaenoic Acid DISRUPTS Platelet function | Nifedipine DISRUPTS Platelet function | Nifedipine TREATS Raynaud Phenomenon |
| 140 | Eicosapentaenoic Acid STIMULATES Epoprostenol | Epoprostenol TREATS Raynaud Phenomenon | ||
| Assoc. | 2.1 | Prostacyclin (PGI2) → AUGMENTS → Erythrocyte Deformability → INHIBITS → blood viscosity → CAUSES → Raynaud Syndrome (in vitro) | ||
| Subgraph | 71 | Eicosapentaenoic Acid DISRUPTS blood viscosity | Ketanserin DISRUPTS blood viscosity | Ketanserin TREATS Raynaud Phenomenon |
| 175 | Fish Oils AFFECTS blood viscosity | |||
| 135 | Eicosapentaenoic Acid STIMULATES Epoprostenol | Epoprostenol TREATS Raynaud Disease | ||
| 150 | Epoprostenol TREATS Raynaud Phenomenon | |||
| Assoc. | 2.2 | Ketanserin → INHIBITS → serotonin → AUGMENTS → Erythrocyte Deformability → INHIBITS → blood viscosity → CAUSES → Raynaud Syndrome | ||
| Subgraph | 71 | Eicosapentaenoic Acid DISRUPTS blood viscosity | Ketanserin DISRUPTS blood viscosity | Ketanserin TREATS Raynaud Phenomenon |
| 175 | Fish Oils AFFECTS blood viscosity | |||
| Assoc. | 3.1 | Prostaglandin (PGE1) → CAUSES → vasodilation → INHIBITS → Raynaud Syndrome | ||
| Assoc. | 3.2 | Prostacyclin (PGI2) → CAUSES → vasodilation → INHIBITS → Raynaud Syndrome | ||
| Subgraph | 25 | Eicosapentaenoic Acid AFFECTS MAN Vascular constriction | Epoprostenol INHIBITS_MAN Vascular constriction | Epoprostenol TREATS Raynaud Disease |
| 26 | Epoprostenol TREATS Raynaud Phenomenon | |||
| Assoc. | 3.3 | Nifedipine → ISA → Calcium Channel Blocker → CAUSES → vasodilation → INHIBITS → Raynaud Syndrome | ||
| Subgraph | 35 | Eicosapentaenoic Acid AFFECTS_MAN Vascular constriction | Nifedipine INHIBITS_MAN Vascular constriction | Nifedipine TREATS Raynaud Phenomenon |